ARTICLE | Company News
Cubist, Evotec deal
March 1, 2010 8:00 AM UTC
The companies added additional undisclosed antibacterial targets to a 2009 deal in which Evotec is using its EVOlution fragment-based drug discovery and its crystallography technology to identify comp...